Progyny, Inc. Unbilled Receivables, Current
Progyny, Inc. (PGNY) had Unbilled Receivables, Current of $36.40 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:UnbilledReceivablesCurrent · last filed 2026-08-07
- 2026-06-30: Unbilled Receivables, Current $36.40M.
- 2026-03-31: Unbilled Receivables, Current $35.40M.
- 2025-12-31: Unbilled Receivables, Current $33.90M.
- 2025-09-30: Unbilled Receivables, Current $44.30M.
| Period end | Unbilled Receivables, Current |
|---|---|
| 2026-06-30 | $36.40M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $35.40M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $33.90M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $44.30M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $49.20M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $58.40M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $47.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $59.50M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $76.50M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $64.90M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $45.10M 10-K · filed 2025-03-03 |
| 2023-09-30 | $49.40M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $45.50M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $49.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $42.90M 10-K · filed 2024-02-29 |
| 2022-09-30 | $65.70M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $36.20M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $31.30M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $23.70M 10-K · filed 2023-03-01 |
| 2021-09-30 | $24.80M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $25.60M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $23.20M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $16.40M 10-K · filed 2022-03-01 |
| 2020-09-30 | $25.00M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $8.50M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $21.10M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $8.50M 10-K · filed 2021-03-01 |
| 2019-09-30 | $9.20M 10-Q · filed 2019-12-06 |
| 2018-12-31 | $3.60M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |